{"doi":"10.1200/op.21.00840","title":"Revisiting\n            <i>UGT1A1</i>\n            Pharmacogenetic Testing Before Irinotecan—Why Not?","abstract":null,"journal":"JCO Oncology Practice","year":2022,"id":612094,"datarank":0.27853739654952364,"base_score":1.6094379124341003,"endowment":1.6094379124341003,"self_citation_contribution":0.24141568686511508,"citation_network_contribution":0.03712170968440854,"self_endowment_contribution":0.24141568686511508,"citer_contribution":0.03712170968440854,"corpus_percentile":null,"corpus_rank":null,"citation_count":4,"citer_count":3,"citers_with_citation_signal":2,"citers_with_endowment":2,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":null,"is_data_producer":false,"deposit_databanks":null,"is_oa":false,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":null,"fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":516276,"name":"Gabriel A. Brooks","orcid":"0000-0003-3984-9995","position":1,"is_corresponding":false},{"id":1575810,"name":"Lukas P. Emery","orcid":"0000-0002-5824-8194","position":0,"is_corresponding":false}],"reference_count":0,"raw_metadata":{"has_enrichment":true,"resolved":true,"title":"Revisiting\n            <i>UGT1A1</i>\n            Pharmacogenetic Testing Before Irinotecan—Why Not?","abstract":null,"is_dataset_classified":null,"base_score":1.3862943611198906,"endowment":1.3862943611198906,"datacite_reuse_total":0,"file_count":0,"downloads":0,"views":0,"has_version_chain":false,"is_dataset":false,"is_oa":false,"pmid":"35108028","pmcid":"PMC9014453","openalex_id":"https://openalex.org/W4210440298","authors":[],"funders":[{"funder_name":"NCI NIH HHS","grant_id":"P30 CA023108","title":null},{"funder_name":"National Institutes of Health","grant_id":"5P30CA023108-40","title":"Cancer Center Support Grant"}],"total_grants":2,"fwci":null,"citation_percentile":null,"influential_citations":0,"citation_trend":[{"year":2024,"count":1},{"year":2025,"count":1},{"year":2026,"count":1}],"oa_status":"green","license":null,"oa_locations":[{"url":"https://www.ncbi.nlm.nih.gov/pmc/articles/9014453","host_type":"repository"},{"url":"https://www.ncbi.nlm.nih.gov/pmc/articles/9014453","host_type":"repository"},{"url":"https://ascopubs.org/doi/pdfdirect/10.1200/OP.21.00840","host_type":"publisher"},{"url":"https://doi.org/10.1200/op.21.00840","host_type":"journal"},{"url":"https://pubmed.ncbi.nlm.nih.gov/35108028","host_type":"repository"}],"fields_of_study":["Cancer therapeutics and mechanisms","Lung Cancer Research Studies","Neutropenia and Cancer Infections","0301 basic medicine","03 medical and health sciences","0302 clinical medicine","Glucuronosyltransferase","Humans","Irinotecan","Pharmacogenomic Testing"],"mesh_terms":["Pharmacogenomic Testing","Irinotecan","Humans","Glucuronosyltransferase"],"keywords":["Pharmacogenetics","MEDLINE","Clinical trial","Genetic testing","Drug","Humans","Glucuronosyltransferase","Irinotecan","Pharmacogenomic Testing"],"sdg_mappings":[],"linked_datasets":[],"clinical_trials":[],"software_tools":[],"database_accessions":[],"source":"live","citation_network_status":"fetched"},"created_at":"2026-08-02T01:27:25.099002Z","pmid":null,"pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}